Tamayo Louis Edward
Chief Financial Officer at LXEO
- Sold, on record
- $44k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Nov 17, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LXEOLexeo Therapeutics, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice LXEONoticeJul 1, 2026 2026
Filed to sell 4,641 shares ($21k)
Tamayo Louis Edward, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale LXEONo planJul 1, 2026 same day
Sold 4,641 shares at $4.49 ($21k)
Tamayo Louis Edward, Chief Financial Officer
No 10b5-1 planSold 4.6% of holdings ($456k position)97,024 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice LXEONoticeAug 18, 2026 +48 days
Filed to sell 4,117 shares ($20k)
Tamayo Louis Edward, Officer
No 10b5-1 planFiling
- 4 Form 4 sale LXEONo planAug 18, 2026 same day
Sold 4,117 shares at $4.91 ($20k)
Tamayo Louis Edward, Chief Financial Officer
No 10b5-1 planSold 4.2% of holdings ($476k position)92,907 shares leftFollows a Form 144Filing
- 5 Form 4 sale LXEONo planNov 17, 2026 +91 days
Sold 1,007 shares at $3.26 ($3k)
Tamayo Louis Edward, Chief Financial Officer
No 10b5-1 planSold 1.1% of holdings ($303k position)91,900 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Nov 18, 2026 | LXEO | Chief Financial Officer | Form 4 sale | 1,007 | $3k | 1.1% | No plan | SEC |
| Aug 18, 2026 | Aug 19, 2026 | LXEO | Chief Financial Officer | Form 4 sale | 4,117 | $20k | 4.2% | No plan | SEC |
| Aug 18, 2026 | Aug 18, 2026 | LXEO | Officer | Form 144 notice | 4,117 | $20k | Notice | SEC | |
| Jul 1, 2026 | Jul 1, 2026 | LXEO | Chief Financial Officer | Form 4 sale | 4,641 | $21k | 4.6% | No plan | SEC |
| Jul 1, 2026 | Jul 1, 2026 | LXEO | Officer | Form 144 notice | 4,641 | $21k | Notice | SEC |